Edinburgh Molecular Imaging company

Edinburgh Molecular Imaging, a Scottish (UK) developer of optical molecular imaging technology. EM Imaging was founded in 2014 by an experienced team of scientists & clinicians. Together they have raised over £15 Million in non-dilutive funding from the Wellcome Trust, EPSRC and MRC to develop a unique range of SMART Agents that enable real-time molecular imaging for the diagnosis of a variety of disease states.
The EM Imaging team has decades of documented success in imaging agent discovery and development with expertise spanning medicinal chemistry, biochemistry and cell biology, along with direct clinical expertise. The team also has significant expertise in the clinical development, approval and reimbursement of molecular imaging agents.
Technology: Regenerative Medicine
Industry: Personalized Medicine
Headquarters: Edinburgh, Edinburgh, City of, United Kingdom
Founded Date: 2014
Employees Number: 1-10
Funding Status: Early Stage Venture
Investors Number: 4
Total Funding: £7.1M
Last Funding Type: Venture - Series Unknown

Visit Website
Register and Claim Ownership